Benedikt, M; Kolesnik, E; Wallner, M; Zirlik, A; Sourij, H; Tripolt, N; Aziz, F; Vonbank, A; Purkarthofer, D; Wester, S; Kopp, K; Nahler, A; von Lewinski, D.
Impact of the SGLT2-inhibitor Empagliflozin on inflammatory biomarkers in acute myocardial infarction-a post-hoc analysis of the EMMY trial
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(S2):S359-S360.-ÖKG Jahrestagung; MAY 31-JUN 3, 2023; Salzburg, AUSTRIA.
[Poster]
Web of Science